Evidence map›Paper›PMID 42627250›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Covalently Linked Peptides and Membrane Potential Enable CyaA Segment Translocation.

Gaia Scilironi, Nicolas Carvalho, Jacinthe Frangieh, Corentin Léger, Dorothée Raoux-Barbot, J Iñaki Guijarro, Daniel Ladant, Sophie Cribier, Nicolas Rodriguez, Alexandre Chenal

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Gaia ScilironiInstitut Pasteur, Université de Paris Cité, CNRS UMR3528, Biochemistry of Macromolecular Interactions Unit, Paris, France.
Nicolas CarvalhoInstitut Pasteur, Université de Paris Cité, CNRS UMR3528, Biochemistry of Macromolecular Interactions Unit, Paris, France.ORCID https://orcid.org/0000-0001-9812-9635
Jacinthe FrangiehInstitut Pasteur, Université de Paris Cité, CNRS UMR3528, Biochemistry of Macromolecular Interactions Unit, Paris, France.ORCID https://orcid.org/0000-0002-3413-8732
Corentin LégerInstitut Pasteur, Université de Paris Cité, CNRS UMR3528, Biochemistry of Macromolecular Interactions Unit, Paris, France.ORCID https://orcid.org/0000-0002-8293-1356
Dorothée Raoux-BarbotInstitut Pasteur, Université de Paris Cité, CNRS UMR3528, Biochemistry of Macromolecular Interactions Unit, Paris, France.
J Iñaki GuijarroInstitut Pasteur, Université de Paris Cité, CNRS UMR3528, Biological NMR and HDX-MS Technological Platform, Paris, France.ORCID https://orcid.org/0000-0002-3826-5245
Daniel LadantInstitut Pasteur, Université de Paris Cité, CNRS UMR3528, Biochemistry of Macromolecular Interactions Unit, Paris, France.ORCID https://orcid.org/0000-0003-1955-548X
Sophie CribierSorbonne Université, École normale supérieure, PSL University, CNRS, Laboratoire Chimie physique et chimie du vivant, CPCV, Paris, France.ORCID https://orcid.org/0000-0001-7727-645X
Nicolas RodriguezSorbonne Université, École normale supérieure, PSL University, CNRS, Laboratoire Chimie physique et chimie du vivant, CPCV, Paris, France.ORCID https://orcid.org/0000-0003-1079-6041
Alexandre ChenalInstitut Pasteur, Université de Paris Cité, CNRS UMR3528, Biochemistry of Macromolecular Interactions Unit, Paris, France.ORCID https://orcid.org/0000-0002-4959-1003

Funding

Agence Nationale de la Recherche ANR 21-CE11-0014CNRS annualdotationInstitut Pasteur DARRI/Emergence2021Institut Pasteur PRCTechfellowshipS-FB14002-85BInstitut Pasteur PTR2023-626Institut Pasteur PTR2023-708Institut Pasteur SPAIS/PTR PTR 2022-502Institut Pasteur ANR ANR 21-CE11-0014-01-3DPasteur-Roux-Cantarini Tech fellowship S-FB14002-85BPasteur-Roux-Cantarini Tech fellowship SPAIS/PTR 502-22Région Ile de France SESAME2014NMRCHRgrant4014526Sorbonne Université CPCVannualdotationSorbonne University and Institut Pasteur PhD program SUIPPhDprogram2022
6 · The paper itself

Abstract

The adenylate cyclase toxin (CyaA) from Bordetella pertussis intoxicates host cells by directly translocating its N-terminal catalytic domain across the plasma membrane; however, the forces driving this unique process remain poorly defined. Here, we dissect the membrane translocation mechanisms of two peptide segments derived from CyaA: P233 and P454 from the catalytic domain and the translocation region, respectively. Both P454 and P233 are calmodulin-binding segments that are sequentially involved in the translocation and activation of the catalytic domain. Using a newly developed Droplet Interface Bilayer (DIB) approach, called DIB-Pipette, which enables direct visualization of peptide transport under controlled membrane potentials, we show that P454 translocates across membranes independently of membrane potential, whereas P233 translocation requires a negative electric membrane potential. Strikingly, covalent coupling of P233 and P454 enables efficient translocation of the resulting peptide even in the absence of a membrane potential. Together, these results suggest that two distinct membrane-active segments within CyaA act cooperatively to promote translocation at the peptide level, revealing an intrinsic mechanism that may contribute to membrane potential-dependent translocation. These findings provide new mechanistic insights into the CyaA cell intoxication process and reveal a multifunctional strategy for protein delivery across membranes.

Indexed as

adenylate cyclasebordetella pertussiscalmodulinCyaA toxinDIB‐Pipettedroplet interface bilayermembrane translocationpeptide translocationprotein membrane interactionprotein–protein interactions

Identifiers

PMID42627250
PMCPMC13495951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.